SWOG clinical trial number
SWOG-425/426
6-Mercaptopurine (NSC-755) and 6-Methylmercaptopurine Riboside (NSC-40774) Combination in the Treatment of Adult Acute Leukemia
Closed
Phase
Accrual
9%
Abbreviated Title
6-Mercaptopurine (NSC-755) and 6-Methylmercaptopurine Riboside (NSC-40774) Combination in the Treatment of Adult Acute Leukemia
Closed
11/04/1969